Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Cloxacillin Sodium Mediphar*

Cloxacillin Sodium Mediphar* :
Type Medicine Non Marketed
Originator Orbenin Capsules*
Agent Pharmapro
Distributor Pharmapro
Laboratory Mediphar
Responsible Party Mediphar Laboratories
Origin Lebanon
Manufacturer Mediphar SAL*
Manufacturing Type G
Origin Lebanon
ATC J01CF02

Your comment will appear shortly after approval

Cloxacillin Sodium Mediphar* :

Revision Date : 14/09/2017


Effect Frequency
Agranulocytosis Uncommon
ALT increased Rare
Anaemia Uncommon
Anaphylactic shock Uncommon
Angioedema (Angioneurotic oedema) (Quincke oedema) Uncommon
AST increased Rare
Diarrhoea, Clostridium difficile Uncommon
DRESS (Drug reaction with eosinophilia and systemic symptoms) Uncommon
Eosinophilia Uncommon
Erythema multiforme Uncommon
Erythroderma Uncommon
Fever Uncommon
Hepatitis cholestatic Very rare
Leucopenia (Leukopenia) Uncommon
Lyell Syndrome (Toxic epidermal necrolysis) Uncommon
Maculopapular rash Uncommon
Nausea Uncommon
Nephropathy Uncommon
Neutropenia Uncommon
Pseudomembranous colitis Rare
Stevens-Johnson syndrome Uncommon
Thrombocytopenia (Thrombopenia) Uncommon
Toxicodermia Uncommon
Urticaria Uncommon
Vomiting Uncommon

Different Units By MoH Code

Revision Date : 01/01/2004

Cloxacillin Sodium Mediphar*  MoH 4391 :
Form Capsule, hard
Package Size Box of 16
Strength 500mg
NSSF ✘
Quarantine ✘
Reg. Number 2827/94
Submission date 01/01/1994
Registration Year 1994
Archived Date 2008


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info